Stay updated on Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Sign up to get notified when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.

Latest updates to the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page
- Check6 days agoChange DetectedNo observable changes between the two screenshots; the study details, eligibility criteria, and trial design appear unchanged.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedAdded a government-operating-status notice and new version v3.2.0; removed old version v3.1.0.SummaryDifference3%

- Check42 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check56 days agoChange DetectedUpdated the page version from v3.0.1 to v3.0.2; removed the Back to Top link.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check71 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new entries related to various chemical compounds and pathological conditions. Notably, several important terms related to cancer treatment, such as azacitidine and pembrolizumab, have been removed.SummaryDifference3%

Stay in the know with updates to Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine Combo with Pembrolizumab & Epacadostat Clinical Trial page.